SCHEMBL20350809

SCHEMBL20350809

Cc1ccc(Cc2cc(=O)[nH]c(SCC(=O)O)c2C#N)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.55
▸ TSHR P16473 1/20 0.52
▸ ALDH1A1 P00352 9/20 0.52
▸ KMT2A Q03164 6/20 0.52
▸ HPGD P15428 3/20 0.52
▸ LMNA P02545 3/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ GAA P10253 2/20 0.47
▸ MAPT P10636 4/20 0.45
▸ MEN1 O00255 4/20 0.45
▸ HTT P42858 3/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ CRHBP P24387 1/20 0.45
▸ CRHR2 Q13324 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ PDE3B Q13370 1/20 0.44
▸ PDE3A Q14432 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ POLB P06746 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20340210 0.90 KDM4E (0.58) KDM4ETSHRALDH1A1KMT2AHPGD
SCHEMBL20340043 0.83 KDM4E (0.64) KDM4ETSHRALDH1A1KMT2AHPGD
SCHEMBL20339853 0.80 KDM4E (0.60) KDM4ETSHRALDH1A1KMT2AHPGD
SCHEMBL23183510 0.79 TSHR (0.80) KDM4ETSHRALDH1A1KMT2AHPGD
SCHEMBL20340192 0.79 KDM4E (0.59) KDM4ETSHRALDH1A1KMT2AHPGD
SCHEMBL24088076 0.79 LMNA (0.55) KDM4ETSHRALDH1A1KMT2AHPGD
SCHEMBL24087892 0.77 LMNA (0.53) KDM4ETSHRALDH1A1KMT2AHPGD
SCHEMBL20350883 0.76 ALDH1A1 (0.47) KDM4ETSHRALDH1A1KMT2AHPGD
SCHEMBL23849883 0.75 ACMSD (0.48) KDM4ETSHRALDH1A1KMT2AHPGD
SCHEMBL24088075 0.74 LMNA (0.51) KDM4ETSHRALDH1A1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018125983-A1 OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS MITOBRIDGE, INC. (US) 2018-07-05 — — WO disclosed
Send feedback